Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 22.74
-0.03 (-0.13%)
Feb 3, 2026, 1:05 PM CST
SHE:002262 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 1,230 | 1,144 | 1,037 | 900.71 | 797.78 | 728.82 |
Depreciation & Amortization | 181.73 | 181.73 | 164.08 | 148.66 | 135.06 | 96.83 |
Other Amortization | 52.47 | 52.47 | 11.01 | 5.09 | 2.78 | 2.5 |
Loss (Gain) From Sale of Assets | -0.29 | -0.29 | -0.15 | -0.37 | 0.24 | 0.15 |
Asset Writedown & Restructuring Costs | -0.07 | -0.07 | -0.22 | 0.28 | 0.74 | 1.03 |
Loss (Gain) From Sale of Investments | -65.57 | -65.57 | -51.04 | -36.27 | -36.23 | -21.49 |
Provision & Write-off of Bad Debts | 33.95 | 33.95 | 15.16 | 1.1 | 6.99 | 2.35 |
Other Operating Activities | -45.21 | 40.78 | 34.29 | 2.09 | 42.38 | 18.98 |
Change in Accounts Receivable | -512.98 | -512.98 | -199.06 | -155.28 | -122.88 | 475.04 |
Change in Inventory | -71.8 | -71.8 | 54.43 | -128.19 | -205.88 | -109.41 |
Change in Accounts Payable | 81.71 | 81.71 | -33.91 | 126.92 | 77.1 | 53.05 |
Change in Other Net Operating Assets | 31.05 | 31.05 | -0.01 | - | 2.49 | 10.9 |
Operating Cash Flow | 916.08 | 916.13 | 1,008 | 861.02 | 701.12 | 1,248 |
Operating Cash Flow Growth | -16.78% | -9.14% | 17.11% | 22.81% | -43.84% | 307.99% |
Capital Expenditures | -403.07 | -450.06 | -373.99 | -327.75 | -206.11 | -268.61 |
Sale of Property, Plant & Equipment | 0.34 | 0.8 | 1.48 | 0.09 | 0.34 | 0.14 |
Cash Acquisitions | -0.38 | -0.34 | -0.13 | - | - | -0.9 |
Divestitures | - | - | - | - | 0.15 | 5.78 |
Investment in Securities | -1,033 | -1,008 | 37 | -393.6 | -221.4 | -677 |
Other Investing Activities | 1,202 | 46.12 | 42.25 | 32.36 | 34.49 | 28.64 |
Investing Cash Flow | -234.4 | -1,411 | -293.39 | -688.9 | -392.52 | -911.95 |
Short-Term Debt Issued | - | - | - | - | - | 38 |
Long-Term Debt Issued | - | 65 | 80 | 40 | 38 | - |
Total Debt Issued | 40.32 | 65 | 80 | 40 | 38 | 38 |
Short-Term Debt Repaid | - | - | - | - | - | -38 |
Long-Term Debt Repaid | - | -141.05 | -87.55 | -78.04 | -62.67 | - |
Total Debt Repaid | -140.98 | -141.05 | -87.55 | -78.04 | -62.67 | -38 |
Net Debt Issued (Repaid) | -100.66 | -76.05 | -7.55 | -38.04 | -24.67 | - |
Issuance of Common Stock | - | 98.86 | - | - | - | - |
Repurchase of Common Stock | - | - | - | - | -0.46 | -201.57 |
Common Dividends Paid | -366.56 | -323.77 | -202.62 | -202.74 | -100.76 | -101.91 |
Other Financing Activities | 21.88 | - | - | - | -1.54 | -1.59 |
Financing Cash Flow | -445.35 | -300.97 | -210.17 | -240.78 | -127.43 | -305.07 |
Foreign Exchange Rate Adjustments | 0.18 | 0.17 | 0.41 | 0.91 | -1.14 | -0.38 |
Net Cash Flow | 236.52 | -796.15 | 505.15 | -67.75 | 180.02 | 30.95 |
Free Cash Flow | 513.01 | 466.07 | 634.31 | 533.27 | 495.01 | 979.74 |
Free Cash Flow Growth | -23.74% | -26.52% | 18.95% | 7.73% | -49.48% | 572.56% |
Free Cash Flow Margin | 8.52% | 8.18% | 12.58% | 12.41% | 12.58% | 29.15% |
Free Cash Flow Per Share | 0.51 | 0.46 | 0.63 | 0.53 | 0.49 | 0.97 |
Cash Interest Paid | - | - | - | - | 5.06 | 1.59 |
Cash Income Tax Paid | 743.67 | 738.14 | 677.61 | 543.1 | 545.21 | 470.14 |
Levered Free Cash Flow | 104.96 | 354.32 | 367.44 | 221.79 | 245.59 | 330.6 |
Unlevered Free Cash Flow | 106.7 | 356.84 | 370.04 | 224.88 | 248.76 | 331.59 |
Change in Working Capital | -470.43 | -470.43 | -201.76 | -160.26 | -248.62 | 419.18 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.